Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 13 | 2025 | 1128 | 3.130 |
Why?
|
| Acute-On-Chronic Liver Failure | 3 | 2023 | 80 | 1.930 |
Why?
|
| Biliary Atresia | 3 | 2023 | 205 | 1.760 |
Why?
|
| Liver Failure, Acute | 4 | 2023 | 96 | 1.190 |
Why?
|
| Adenovirus Infections, Human | 2 | 2023 | 57 | 0.980 |
Why?
|
| Varicose Veins | 1 | 2022 | 31 | 0.790 |
Why?
|
| Registries | 4 | 2025 | 1571 | 0.780 |
Why?
|
| Hepatorenal Syndrome | 1 | 2022 | 32 | 0.780 |
Why?
|
| Liver Cirrhosis | 4 | 2022 | 935 | 0.760 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2022 | 74 | 0.760 |
Why?
|
| End Stage Liver Disease | 2 | 2025 | 203 | 0.750 |
Why?
|
| Hypertension, Portal | 1 | 2022 | 81 | 0.750 |
Why?
|
| Hepatic Artery | 3 | 2022 | 51 | 0.730 |
Why?
|
| Respiratory Insufficiency | 2 | 2022 | 240 | 0.720 |
Why?
|
| Gastroenterology | 1 | 2024 | 210 | 0.710 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 315 | 0.690 |
Why?
|
| Bradycardia | 1 | 2020 | 63 | 0.680 |
Why?
|
| Dexmedetomidine | 1 | 2020 | 50 | 0.660 |
Why?
|
| Gastroenteritis | 1 | 2023 | 365 | 0.650 |
Why?
|
| Hypnotics and Sedatives | 1 | 2020 | 138 | 0.630 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 139 | 0.620 |
Why?
|
| Thrombosis | 3 | 2022 | 540 | 0.610 |
Why?
|
| Patient Admission | 1 | 2020 | 190 | 0.610 |
Why?
|
| Curriculum | 1 | 2024 | 772 | 0.590 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2017 | 15 | 0.540 |
Why?
|
| Liver | 2 | 2021 | 1878 | 0.500 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 427 | 0.490 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2017 | 244 | 0.480 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 239 | 0.460 |
Why?
|
| Pediatrics | 1 | 2024 | 1218 | 0.450 |
Why?
|
| Infant | 11 | 2025 | 13173 | 0.410 |
Why?
|
| Postoperative Complications | 3 | 2025 | 3167 | 0.390 |
Why?
|
| Adenoviruses, Human | 2 | 2023 | 99 | 0.390 |
Why?
|
| Child | 13 | 2025 | 25765 | 0.380 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 770 | 0.350 |
Why?
|
| Retrospective Studies | 11 | 2025 | 17421 | 0.340 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 1874 | 0.290 |
Why?
|
| Child, Preschool | 7 | 2025 | 14805 | 0.270 |
Why?
|
| Humans | 19 | 2025 | 133705 | 0.260 |
Why?
|
| Infant, Newborn | 5 | 2025 | 8589 | 0.250 |
Why?
|
| Hospitalization | 4 | 2025 | 1897 | 0.240 |
Why?
|
| Waiting Lists | 2 | 2025 | 244 | 0.230 |
Why?
|
| Cholestasis | 1 | 2025 | 158 | 0.200 |
Why?
|
| Peritonitis | 1 | 2022 | 80 | 0.200 |
Why?
|
| Ascites | 1 | 2022 | 99 | 0.190 |
Why?
|
| Bacterial Infections | 1 | 2025 | 327 | 0.190 |
Why?
|
| Hepatitis | 1 | 2022 | 57 | 0.190 |
Why?
|
| Health Care Costs | 1 | 2025 | 407 | 0.180 |
Why?
|
| Hemochromatosis | 1 | 2021 | 38 | 0.180 |
Why?
|
| Antithrombins | 1 | 2021 | 57 | 0.180 |
Why?
|
| Societies, Medical | 1 | 2025 | 776 | 0.170 |
Why?
|
| Liver Failure | 1 | 2021 | 91 | 0.170 |
Why?
|
| Adolescent | 5 | 2025 | 20520 | 0.170 |
Why?
|
| Venous Thrombosis | 1 | 2022 | 168 | 0.170 |
Why?
|
| International Normalized Ratio | 1 | 2020 | 44 | 0.170 |
Why?
|
| Male | 8 | 2025 | 65850 | 0.170 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 86 | 0.170 |
Why?
|
| Adenoviridae | 1 | 2023 | 610 | 0.160 |
Why?
|
| Forecasting | 1 | 2021 | 376 | 0.160 |
Why?
|
| Female | 7 | 2025 | 71603 | 0.160 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 560 | 0.150 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 144 | 0.150 |
Why?
|
| Length of Stay | 2 | 2025 | 1387 | 0.150 |
Why?
|
| Creatinine | 1 | 2020 | 429 | 0.150 |
Why?
|
| Liver Diseases | 1 | 2022 | 390 | 0.140 |
Why?
|
| Philadelphia | 1 | 2017 | 27 | 0.140 |
Why?
|
| Peptide Fragments | 1 | 2021 | 833 | 0.130 |
Why?
|
| Clinical Competence | 1 | 2024 | 1068 | 0.130 |
Why?
|
| Treatment Outcome | 4 | 2025 | 13001 | 0.130 |
Why?
|
| Intensive Care Units | 1 | 2020 | 538 | 0.130 |
Why?
|
| Remission, Spontaneous | 1 | 2016 | 69 | 0.130 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2016 | 25 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2016 | 59 | 0.120 |
Why?
|
| Anticoagulants | 2 | 2022 | 603 | 0.120 |
Why?
|
| Early Diagnosis | 1 | 2016 | 197 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2020 | 1090 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 211 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2016 | 225 | 0.110 |
Why?
|
| Recurrence | 1 | 2017 | 1470 | 0.100 |
Why?
|
| Risk Factors | 3 | 2025 | 11112 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 788 | 0.090 |
Why?
|
| Prognosis | 1 | 2020 | 5073 | 0.080 |
Why?
|
| Heart Failure | 1 | 2022 | 2424 | 0.080 |
Why?
|
| Constriction, Pathologic | 1 | 2025 | 239 | 0.060 |
Why?
|
| Young Adult | 1 | 2017 | 9873 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2024 | 157 | 0.050 |
Why?
|
| Portal Vein | 1 | 2022 | 95 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 89 | 0.050 |
Why?
|
| Viremia | 1 | 2022 | 135 | 0.050 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2021 | 34 | 0.050 |
Why?
|
| Hirudins | 1 | 2021 | 40 | 0.050 |
Why?
|
| Graft Survival | 1 | 2022 | 557 | 0.040 |
Why?
|
| Acute Disease | 1 | 2022 | 1191 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 1439 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2989 | 0.030 |
Why?
|
| Adult | 1 | 2024 | 31872 | 0.010 |
Why?
|